Successful treatment of neonatal rhesus hemolytic anemia with high doses of recombinant human erythropoietin.

@article{Wacker2001SuccessfulTO,
  title={Successful treatment of neonatal rhesus hemolytic anemia with high doses of recombinant human erythropoietin.},
  author={Pierre Wacker and Hulya Ozsahin and M J Stelling and James Humbert},
  journal={Pediatric hematology and oncology},
  year={2001},
  volume={18 4},
  pages={279-82}
}
The authors report the use of high-dose recombinant erythropoietin (r-HuEPO) in a full-term newborn baby with severe postnatal rhesus hemolytic anemia (RHA). Hemoglobin (Hb) value and reticulocyte count at day 13 of life were 59 g/L and 234 x 10(9)/L, respectively. Three days after the r-HuEPO (870 U/kg/d) administration, reticulocyte count had increased more than 4-fold and Hb rose to 73 g/L. r-HuEPO was gradually decreased after 18 days of treatment. No major side effect was observed. In… CONTINUE READING